Showing results (1061-1070 of 1,214) with videos related to
Sort By:
Pageof 122
European Archives of Psychiatry and Clinical Neuroscience|May 2, 2025
Plasma biomarkers of amyloid, tau & neuroinflammation in Alzheimer's disease and corticobasal syndromeCarolin Kurz, Laura Carli, Selim Üstün Gürsel, et al.The British Journal of Dermatology|May 24, 2022
Biomarkers of systemic treatment response in people with psoriasis: a scoping reviewMark Corbett, Ravi Ramessur, David Marshall, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.Zeitschrift Fur Gesundheitswissenschaften = Journal of Public Health|June 26, 2023
Development of a risk score to identify patients at high risk for a severe course of COVID-19Josephine Jacob, Falko Tesch, Danny Wende, et al.JACC. Cardiovascular Interventions|August 25, 2022
Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV RepairCarolina Donà, Christian Nitsche, Matthias Koschutnik, et al.Journal of Personalized Medicine|April 30, 2021
Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal MelanomatosisAlicia Baumgartner, Natalia Stepien, Lisa Mayr, et al.The Journal of Allergy and Clinical Immunology|April 22, 2018
Eleven loci with new reproducible genetic associations with allergic disease riskManuel A R Ferreira, Judith M Vonk, Hansjörg Baurecht, et al.The British Journal of Dermatology|April 28, 2022
Biomarkers of disease progression in people with psoriasis: a scoping reviewRavi Ramessur, Mark Corbett, David Marshall, et al.Dermatology (Basel, Switzerland)|May 6, 1998
Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerabilityH Zachariae, B Abrams, S S Bleehen, et al.Oncotarget|September 8, 2018
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissueMichael Forster, Adam Mark, Friederike Egberts, et al.Pageof 122